by Tiphaine Gaillard, Sébastien Briolant, Marylin Madamet  et al.
Malaria Journal, 2017, 16:148 – Published: 13 April 2017

5 pp. 926 kB
https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-017-1797-9?
site=malariajournal.biomedcentral.com

Anti-malarial drug resistance to chloroquine and sulfadoxine–pyrimethamine has spread from Southeast Asia to Africa. Furthermore, the recent emergence of resistance to artemisinin-based combination therapy (ACT) in Southeast Asia highlights the need to identify new anti-malarial drugs. Doxycycline is not used in young children under 8 years of age due to its contraindication due to the risk of yellow tooth discolouration and dental enamel hypoplasia. However, recent studies report little or no effects of doxycycline on tooth staining or dental enamel hypoplasia in children under 8 years of age. It is time to rehabilitate doxycycline and to recommend it for malaria treatment in children under 8 years of age.

(Visited 12 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria, Maternal & Child Health. Bookmark the permalink.
Facebook Auto Publish Powered By : XYZScripts.com
Get the latest issue of the NewsletterDownload